Correct answer: E, IL-17

Nail psoriasis, characterized here by irregular nail pitting and distal onycholysis, responds to treatment against IL-17 including secukinumab, ixekizumab, and brodalumab

Test your knowledge with custom quizzes at Derm In-Review or check out more pop quizzes.

Brought to you by our Brand Partner